GGrantIndex
Sort

1,049,261 grants matching t cell

Medical Oncology Fellowship Program

$5,199,880
Antonio Fojo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

CREST Center for Cellular and Biomolecular Machines

$5,198,804
Victor Munoz · University Of California - Merced · · FY2016 · EDU

Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

$5,198,360
Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI

THIS PROJECT IS DIRECTED AT IDENTIFYING, TESTING, AND IMPLEMENTING WITHIN 2 YEARS ULTRAVIOLET LIGHT (UV)+TEMPERATURE TOLERANT MATERIALS AND CELL STACK DESIGNS FOR 27% MECHANICALLY-STACKED PEROVSKITE+SILICON HYBRID TANDEM PHOTOVOLTAIC (PV) MODULES WITH =300 CM2 APERTURE AREAS THAT PASS IEC 61215 MODULE QUALITY TEST (MQT) 10, 11, 13, AND 21 AND ISOS-L-2 AND EXHIBIT <3% RELATIVE POWER LOSS AFTER 6 MONTHS OF CONTINUOUS OUTDOOR OPERATION.

$5,197,852
Tandem Pv, Inc. · · FY2025 · Department of Energy

Investigating the neural mechanisms of human cognitive function through intracranial recordings

$5,197,638
Kareem Zaghloul · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Molecular Regulation of B cells and T cells in Human SLE

$5,194,108
Ignacio E. Sanz · Emory University · U19 · FY2019 · AI

Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents

$5,193,433
Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

The Baltimore Longitudinal Study of Aging

$5,190,224
Luigi Ferrucci · National Institute On Aging · ZIA · FY2013 · AG

MPD Research Consortium

$5,185,968
Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · CA

Univ. Michigan Comprehensive Cancer Center Support Grant

$5,184,039
University Of Michigan At Ann Arbor · P30 · FY2004 · CA

Innovative Platforms for Antimicrobial Therapy and Vaccine Development

$5,183,191
Dennis L. Kasper · Harvard Medical School · U19 · FY2017 · AI

Blood & Marrow Transplant Clinical Trials Network Data Coordinating Center

$5,181,259
Mary M Horowitz · Medical College Of Wisconsin · U10 · FY2015 · HL

Helping to End Addiction Long-term (HEAL): New Chemical Structures for Pain, Addiction and Overdose Targets

$5,180,300
Samuel Michael · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Cancer Center Support Grant

$5,179,933
Jennifer A Pietenpol · Vanderbilt University · P30 · FY2007 · CA

SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER

$5,176,856
John Wayne Cancer Institute · P01 · FY2004 · CA

Genetic and epigenetic regulation of retinal development, aging and evolution

$5,173,977
Anand Swaroop · National Eye Institute · ZIA · FY2022 · EY

Human Biochemical Genetics

$5,173,827
William Gahl · National Human Genome Research Institute · ZIA · FY2021 · HG

Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells

$5,172,790
David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc. · U01 · FY2008 · HG

STEM CELLS THERAPEUTICS FOR MILITARY RELEVANT BRIAN INJURY USING AMNOIN-DERIVED MULTIPOTENT PROGENITOR (AMP) CELLS

$5,172,544
The Geneva Foundation · · FY2008 · Department of Defense

RII Track-2 FEC: From Genome to Phenome in a Stressful World: Epigenetic Regulatory Mechanisms Mediating Thermal Plasticity in Drosophila

$5,171,722
Sara I Cahan · University Of Vermont & State Agricultural College · · FY2018 · O/D

Phase 3 trial of inosine for Parkinson's disease CCC

$5,170,824
Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2015 · NS

SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER

$5,170,798
John Wayne Cancer Institute · P01 · FY2002 · CA

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY

$5,169,515
Marianne Ward · Duke University · N01 · FY2013 · AI

Developing Antivirals Targeting Proteases and Polymerases of Coronaviruses, Picornaviruses and Bunyavirales

$5,168,269
Charles Scott Craik · University Of California, San Francisco · U19 · FY2022 · AI

Molecular Basis of Cholesterol Metabolism

$5,166,033
Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2006 · HL